¹B°Ê¥Í²z¾Çºô¯¸ ·|­û¡G¥¼µn¿ý¡@µn¤J¡@§Ñ°O±K½X¡@¥Ó½Ð¥[¤J·|­û ¡@·|­û9724 ¡@³¡¸¨®æ5¡@¡@


¹B°Ê¥Í²z¶g°T ¹B°Ê¥Í²z¶g°T(³Ì·s¦^À³) ¦^¶g°T­º­¶

¹B°Ê¥Í²z¶g°T¹B°Ê¥Í²z¶g°T¹q¤l³ø
Online ISSN : 1814-7712
ª©Åv©Ò¦³ ¥¼¸g¦P·N ½Ð¤ÅÂà¸ü©Î¸`¿ý

¹B°Ê±`ÃÑ °V½m·§½× ¯à¶q¨Ó·½ ©I§l´`Àô ¦Ù¦×°©Àf ¹B°ÊÅé¯à °V½m¤èªk
¨­Åé²Õ¦¨ ¹B°ÊÀç¾i ¹B°ÊÀô¹Ò ¹B°Ê¶Ë®` ¬ã¨s¤èªk ºô¯¸µo®i ¬ÛÃö°T®§

¥DÃD¡G¦Ù¤O°V½m­°§C¦º¤`²v
µo¨¥ : scwang ®É¶¡ : 19/09/01(22:08:31) From : 115.82.34.107 ¤ÀÃþ : ¦Ù¦×°©Àf
¹B°Ê¥Í²z¶g°T(²Ä389´Á)

¦Ù¤O°V½m­°§C¦º¤`²v(September 1, 2019)

¤ý¶¶¥¿¡BªL¥Éã¡B§d±á¸t¡B¸ô¥lÁ¨¡B§d¬f¿«

¡@¡@¦Ñ¤Æ¬O¨C­Ó¤H³£­n­±¹ïªº¶¥¬q¡A´£¤É¦Ñ¦~¤Hªº¨­Åé¾÷¯à¡B°·±d¦Ñ¤Æ«h¬O²{¥N°ªÄ֤ƪÀ·|ªº­«­n½ÒÃD¡C¦³Ãö¦Ñ¦~¤H¦Ù¦×¾÷¯à»P¦º¤`²vªº¬ÛÃö¬ã¨s¬Û·í¦h¡A¤j³¡¤À¬ã¨s³£µo²{¡A¦Ù¤O°V½m¹ï©ó­°§C¦Ñ¦~¤H¦º¤`²v¦³ÅãµÛªºÀ°§U¡C

¦Ù¤O°V½m­°§C¦º¤`²v¡@¡@Ruizµ¥ (2008) ¶i¦æªø¹F18.9¦~¡B¥H10265¦W¨k©Ê¬ã¨s¹ï¶H¡BÁ`¦@¹F165251¤H¦~ (person years) ¬ö¿ýªºÁa¦V¬ã¨s (Cooper Clinic in Dallas)¡A¦b¬ã¨s´Á¶¡Á`¦@¦³503¤H (5.7%) ¬ã¨s¹ï¶H¦º¤`¡A¨ä¤¤¦]¤ßªÍ¯e¯f¦º¤`¦³145¤H (¦º¤`¤H¼Æªº28.8%)¡B¦]Àù¯g¦º¤`¦³199¤H (¦º¤`¤H¼Æªº39.6%)¡C°w¹ï©Ò¦³¨ü¸Õ¹ï¶H¸ê®Æ¡A¦Ù¤O¸û®t1/3ªº¦º¤`²v¬O¦Ù¤O¤¤¶¡1/3¡B¦Ù¤O¸û¦n1/3ªº1.50 (38.9/25.9) ­¿¡B1.46 (38.9/26.6) ­¿ (¥k¹Ï¤W)¡F°w¹ï¤ßªÍ¯e¯f¦º¤`ªº¸ê®Æ¨Ó¬Ý¡A¦Ù¤O¸û®t1/3ªº¦º¤`²v¤À§O¬O¨ä¥L¨â²Õªº1.83 (12.1/6.6) ­¿¡B1.59 (12.1/7.6) ­¿¡F°w¹ïÀù¯g¦º¤`ªº¸ê®Æ¨Ó¬Ý¡A¦Ù¤O¸û®t1/3ªº¦º¤`²v«h¤À§O¬O¨ä¥L¨â²Õªº1.45 (6.1/4.2) ­¿¡B1.24 (6.1/4.9) ­¿¡C¬ã¨sµ²ªGÅã¥Ü¡A¬ü°ê¨k©Ê°ªÄ̡֪A¤£ºÞÅé­«¥¿±`©Î¶W­«¡B©ÎªÌ¦~ÄÖ°ª§C¡A¦Ù¤O»P¦º¤`²v¦¨­t¬ÛÃö¡A¤]¬O´N»¡¦Ù¤O¶V§C¦º¤`²v¶V°ª¡C¥Ñ¤U¹Ïªº¸ê®ÆÅã¥Ü¡A¾¨ºÞ¤ßªÍ¥\¯à¸û¦nªÌªº¦º¤`²v·|ÅãµÛ¤U­°¡A¦ý¬O·í¦Ù¤O¸û®t®É¡A¤£ºÞ¤ßªÍ¥\¯à¦n¤£¦n¡A¦º¤`²v³£·|ÅãµÛ´£°ª¡C¥Ñ¦¹¥i¨£¡A´£¤É°ªÄÖ¨k©Êªº¦Ù¤O¥i¥H­°§C¦º¤`²v¡C

¦Ù¤O°V½m­°§C¦º¤`²v
¤£ºÞ¤ßªÍ¥\¯à¦nÃa¦Ù¦×¤O¶q¸û®t³£·|´£°ª¦º¤`²v (Ruizµ¥, 2008)

¦Ù¤O°V½m­°§C¦º¤`²v¡@¡@Kamadaµ¥ (2017) ¥H2001¦~¨ì2005¦~¶}©l¶i¦æªº°ü¤k°·±d¬ã¨s¡A28879¦W¬ü°ê¤k©Ê (¥­§¡¶}©l¦~ÄÖ62.2·³¡B¥B¨S¦³¤ß¦åºÞ¯e¯f¡B¿}§¿¯f©MÀù¯g) ¬°¹ï¶H¡A¬ã¨sµo²{¦b¸g¹L12¦~¤§«á§e²{3055¦º¤`¯f¨Ò (411¨Ò¦º©ó¤ß¦åºÞ¯e¯f¡A748¨Ò¦º©óÀù¯g)¡A¦b±Æ°£¨­Å鬡°Ê¶qªº¼vÅT¤U¡A¤­Ãþ¦Ù¤O°V½m®É¶¡ (0, 1-19, 20-59, 60-149, ≥150 ¤ÀÄÁ/¶g) ªº­·ÀI¤ñ (hazard ratios) ¤À§O¬°1, 0.73, 0.71, 0.81, 1.10 (»P¨S¦³¦Ù¤O°V½mªÌ¤ñ¸û)¡C¬ã¨sÅã¥Ü¦Ù¤O°V½m®É¶¡»P¦º¤`²vªºJ§ÎÃö«Y¡A°w¹ï¤k©Ê°ªÄ֪̤O¶q°V½m®É¶¡¨C¶g1-145¤ÀÄÁ¡A­·ÀI¤ñ·|¤p©ó¤£¶i¦æ¦Ù¤O°V½mªÌ¡C·í¦Ù¤O°V½m®É¶¡°ª©ó¨C¶g150¤ÀÄÁ«á¡A¤Ï¦Ó·|´£°ª­·ÀI¤ñªº²{¶H¡A¦ü¥G¦³¶i¤@¨B¬ã¨sªº»Ý­n¡C¬ã¨sµ²ªGÅã¥Ü¡A¤k©Ê°ªÄ̶֪i¦æ¾A«×¤O¶q°V½m¦³¯q©óªø¹Ø¡C

¡@¡@Volaklisµ¥ (2015) ¾ã²z1980¦Ü2014¦~¦@23½g¾Ç³N½×¤å (15½g¬y¦æ¯f¾Ç¬ã¨s¡B8½gÁ{§É¬ã¨s)¡Aµo²{¦Ù¦×¤O¶q»P¦º¤`²v¦¨¤Ï¤ñ¡B¦Ó¥B¿W¥ß¬ÛÃö¡C¬ã¨s½×¤å«ü¥X¡A¤O¶q°V½m­°§Cµo¯f²v¡B¦º¤`²vªº«OÅ@¾÷¨î¡A¥]¬A§ïµ½¤ß¦åºÞ¦MÀI¦]¯À (¦p¦åÀ£¡BÅé¯×©Î¦å¯×)¡B­°§C¯Ø®q¯Àªý§Ü¡B§ïµ½¦Ù¦×¥\¯à©M¦Ù¦×½è¶q¡B´£°ª°ò¦¥NÁ²v¡B­°§C¶^­Ëªº­·ÀI¡B¹w¨¾¦Ñ¤Æ¹Lµ{¤¤°©½è¬y¥¢¡B´î¤Ö¨t²Î©Êµoª¢¯gª¬¡B§ïµ½»{ª¾¥\¯à¡B§ïµ½¥Í¬¡½è¶q©M¤é±`¥Í¬¡¬¡°Ê¡C¥Ñ¦¹¥i¨£¡A¤O¶q°V½m¹ï©óºû«ù°·±dªº­«­n©Ê¡C

¦Ù¤O°V½m­°§C¦º¤`²v¡@¡@Mcleodµ¥ (2019) ¦b¤åÄm±´°Qªº½×¤å¤¤´£¥X¡A¤j¦h¼Æ¨­Å鬡°Ê«ü«n±j½Õ¨C¶g150¤ÀÄÁªº¤¤«×¦Ü±j¤O¡B75¤ÀÄÁªº¼@¯P¦³®ñ¹B°Ê°V½m (aerobic exercise training, AET)¡A¥H´î¤ÖºC©Ê¯e¯f (¦æ°Ê¤£«K¡B¤ß¦åºÞ¯e¯f¡BII«¬¿}§¿¯f¡BÀù¯g) ªº­·ÀI¡Cªý¤O¹B°Ê°V½m ( resistance exercise training, RET) ¦ü¥G»PAET¤@¼Ë¦³®Ä­°§C´XºØºC©Ê¯fªº­·ÀI¡CRET¥i¥H§ïµ½¨­Åé²Õ¦¨¡B§ïµ½¦åÀ£¡B§ïµ½¦å¿}©M¯Ø®q¯À±Ó·P©Ê¡B§ïµ½¤F¨­Åé¾÷¯à©M¬¡°Ê¯à¤O¡B§ïµ½¦å¯×©M¦åºÞ¥\¯à¡B§ïµ½§K¬Ì¨t²Î¥\¯à¡B¦Ù¦×½è¶q©M¤O¶q¼W¥[¡B§ó°ªªº®ñ¤Æ¯à¤O (¥k¹Ï)¡C¦Ù¤O°V½m¤£¦ý¥i¥H¹F¨ì¦³®ñ°V½mªº¬Û¦P®ÄªG¡AÁÙ¥i¥H´£°ª¦Ù¦×¶q»P¦Ù¤O¡A¶i¦Ó­°§C¿©±wºC©Ê¯fªº­·ÀI¡C

¦Ù¤O°V½m­°§C¦º¤`²v¡@¡@¨Ì¾Ú¦Ñ¤ÆªºÁa¦V¬ã¨sµ²ªG¡A¦Ñ¦~¤Hªº¦Ù¤O¶V§C¡B¦º¤`²v¶V°ª¡A¦Ó¥B¨k¤k¬Ò¦³¤@¼ËªºÁͶաC¬°¤F°·±d¦Ñ¤Æªº»Ý­n¡A¦Ñ¦~¤H¶i¦æ¦Ù¤O°V½m¬O¬Û·í¥²­nªº°·±d¤â¬q¡C¨Ì¾ÚMcleodµ¥ (2019) ¹ï©ó¦Ñ¦~¤Hªý¤O¹B°Ê°V½mªº«ØÄ³ (¥k¹Ï)¡A¨C¶g¨â¦¸¡B¥þ¨­©Êªºº¥¼W­t²ü°V½m¡A­t²ü¥H30%-69% 1 RMªº­«¶q°V½m (> 13 ¦¸¡A¶i¦æ¨ì¯h³Ò)¡B©ÎªÌ±Ä¥Î°V½mªÌ¦Û¨­Åé­«¶i¦æªý¤O¹B°Ê°V½m (¶i¦æ¨ì¯h³Ò) ªº°V½m®ÄªG¡A»P±Ä¥Î≥70% 1RMªº¦Ù¤O°V½m®ÄªGÃþ¦ü¡A¥u­n°V½m¶q¥i¥H«ùÄò¶i¦æ¨ì¦Ûı¯h³Ò (volitional fatigue)¡C

¡@¡@¦Ù¤O¸û¨Îªº¦Ñ¦~¤H¦º¤`²v¤ñ¸û§C¡A¦Ó¥B¦³®ñ¹B°Ê¯à¤O¸û¨Îªº¦Ñ¦~¤H¡A¦pªG¦Ù¤O¤£¨Î¤]·|ÅãµÛ¼W¥[¦º¤`²v¡C¦Ù¤O°V½m¥i¥H°µ¬°´£¤É¦Ñ¦~¤H¨­Å鬡°Ê¶qªº¦³®Ä¤u¨ã¤§¤@¡C¦Ñ¦~¤H¦Ù¤O°V½mªº¤è¦¡¡A«ØÄ³¨C¶g¶i¦æ¨â¦¸¡A±Ä¥Î¥þ¨­©Êªºº¥¼W­t²ü¦Ù¤O°V½m¤è¦¡¶i¦æ°V½m¡A°V½m­t²ü±Ä¥Î¦Û¨­Åé­«¡B©ÎªÌ±Ä¥Î§C¨ì¤¤µ¥­t²ü (30%-69% 1 RM) ¶i¦æªý¤O¹B°Ê°V½m®É¡A«ØÄ³°V½m¶q (¤ÏÂЦ¸¼Æ) ­n¶i¦æ¨ì¦Ûı¯h³Òªºµ{«×¡A§_«h±Ä¥Î≥70% 1RMªº­t²ü¶i¦æªý¤O¹B°Ê°V½m®ÄªG¸û¨Î¡C

¤Þ¥Î¤åÄm

Ruiz, J. R., Sui, X., Lobelo, F., Morrow Jr, J. R., Jackson, A. W., Sjostrom, M., & Blair, S. N. (2008). Association between muscular strength and mortality in men: prospective cohort study. British Medical Journal, 337, a439.

Kamada, M., Shiroma, E. J., Buring, J. E., Miyachi, M., & Lee, I-M. (2017). Strength training and all‐cause, cardiovascular disease, and cancer mortality in older women: a cohort study. Journal of the American Heart Association, 6(11), e007677.

Mcleod, J. C., Stokes, T., & Phillips, S. M. (2019). Resistance exercise training as a primary countermeasure to age-related chronic disease. Frontiers in Physiology, 10, 645. doi: 10.3389/fphys, 2019.00645

Volaklis, K. A., Halle, M., & Meisinger, C. (2015). Muscular strength as a strong predictor of mortality: a narrative review. European Journal of Internal Medicine, 26, 303-310.

¡@¦@¦³ 0 ¦^À³


¡@¡@¦^¤W­¶ ¡@¡@µoªí¦^À³
 B ʥͲz Ǻ
 B ʥͲz Ǻ     Ǥƶ] B V m
 B ʥͲz Ǻ    x W   a V m A ȥ  x
 B ʥͲz Ǻ      Z w   P V m B
    (PFQ) [ c
 B ʥͲz Ǻ    C ֦~    פ  R
 B ʥͲz Ǻ   YouTube W D
°µ­Ó¦³´¼¼zªº¶]ªÌ

epsport-ad

 j M     ҾǥZ

¹B°Ê¥Í²z¾Çºô¯¸
¹B°Ê¬ì¾Ç±Ð¨|¬ã¨s«Ç